AstraZeneca (OTCMKTS:AZNCF) Trading Up 1.6% – What’s Next?

AstraZeneca PLC (OTCMKTS:AZNCF)’s stock price was up 1.6% during mid-day trading on Wednesday . The company traded as high as $181.92 and last traded at $181.92. Approximately 822 shares changed hands during trading, a decline of 70% from the average daily volume of 2,765 shares. The stock had previously closed at $179.0999.

AstraZeneca Stock Performance

The stock has a 50 day moving average price of $173.21 and a 200-day moving average price of $157.65.

Hedge Funds Weigh In On AstraZeneca

An institutional investor recently raised its position in AstraZeneca stock. Boston Common Asset Management LLC raised its stake in AstraZeneca PLC (OTCMKTS:AZNCF) by 5.6% in the 3rd quarter, according to its most recent disclosure with the SEC. The fund owned 192,589 shares of the company’s stock after purchasing an additional 10,154 shares during the quarter. Boston Common Asset Management LLC’s holdings in AstraZeneca were worth $28,992,000 at the end of the most recent quarter. 40.87% of the stock is owned by institutional investors.

AstraZeneca Company Profile

AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.